Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Tamara Ghanem

- PMLiVE

Oxford University, Prenetics to advance COVID-19 rapid testing for other infectious diseases

Rapid testing technology at the core of the collaboration is used in Oxford University's COVID-19 test

Biogen Idec building

Biogen reveals new data for MS therapies Tysabri and Vumerity

New data comes ahead of FDA decision on company's controversial Alzheimer’s drug aducanumab

- PMLiVE

Hanover Health appoints two new associate directors

Donna Curran joins the communications team and Mark MacDonald joins the public affairs practice

Roche Basel Switzerland

Roche reports strong diagnostics sales in Q1 as demand for COVID-19 tests continues

Company continues to report a significant impact of biosimilar competition on established brands

- PMLiVE

Havas Health & You appoints Pat Thistlethwaite as chief experience officer

In addition to taking on the new role, Thistlethwaite will continue to serve as managing director

Empowering patients empowers results

Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials

- PMLiVE

Vertex to lead development of CRISPR Therapeutics-partnered gene therapy

Amended agreement sees Vertex take control of gene therapy programme

- PMLiVE

EMA finds overall benefit-risk ‘remains positive’ for J&J COVID-19 vaccine

Safety committee finds possible link to ‘very rare cases’ of unusual blood blots with low blood platelets

- PMLiVE

Health leaders welcome EDPB’s opinion on adequacy of UK’s data protection standards

Opinion ‘paves way’ for sharing of health data between EU and the UK

- PMLiVE

bluebird bio anticipates lift of clinical holds on LentiGlobin in mid-2021

Previously reported case of MDS in phase 1/2 study has been re-classified as transfusion-dependent anaemia

- PMLiVE

WHO director-general says pandemic can be brought under control within months

World has tools to curb pandemic if applied ‘consistently and equitably’

- PMLiVE

NICE sets out plans for ‘ambitious’ five-year strategy

NICE refocuses on reducing health inequalities and accelerating access to the latest and most effective treatments

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links